What is the aspiration risk for patients receiving BiPAP (bilevel positive airway pressure) and how should it be assessed and mitigated?

Risk of Aspiration in Patients on BiPAP

Patients receiving BiPAP are at increased risk of aspiration, particularly when using BiPAP mode compared to CPAP, and this risk must be carefully assessed and mitigated through specific clinical protocols.

Understanding the Aspiration Risk with BiPAP

BiPAP increases aspiration risk through a specific mechanism: the bilevel pressure support can trigger inspiratory flow immediately after swallowing, disrupting the normal respiratory-swallow coordination. Research demonstrates that BiPAP significantly increases the occurrence rate of inspiration immediately after swallowing compared to both spontaneous breathing and CPAP 1. This happens because swallow-related non-inspiratory flow may inadvertently trigger the device's inspiratory support, forcing air into the airway at the exact moment when the airway should remain closed post-swallow.

The risk is present regardless of patient age, though older patients face compounded risk factors 1, 2.

Clinical Assessment Algorithm

Step 1: Identify High-Risk Patients

Patients requiring BiPAP who have ANY of the following should be flagged for aspiration risk 3, 4, 3:

• Neurological conditions: stroke (especially brainstem or bilateral), neuromuscular disease, depressed consciousness
• Structural issues: cranial nerve palsies, dysphonia, dysarthria
• Functional impairments: abnormal gag reflex, impaired voluntary cough, wet/gurgly voice quality
• Clinical history: recurrent pneumonia, unexplained cough while eating/drinking, fear of choking

Step 2: Bedside Screening Before BiPAP Initiation

For alert patients, perform a 3-ounce water swallow test while observing for 3:

• Coughing during or after swallowing
• Wet voice quality (gurgling sound on phonation)
• Throat clearing
• Incomplete oral-labial closure

If ANY of these signs are present, refer immediately to speech-language pathologist for videofluoroscopic swallow evaluation (VSE) or fiberoptic endoscopic evaluation of swallowing (FEES) BEFORE initiating BiPAP 3.

Step 3: NPO Status for High-Risk Patients

Patients with reduced level of consciousness must remain NPO (nothing by mouth) until consciousness improves 3. Do not attempt oral feeding regardless of BiPAP settings.

Risk Mitigation Strategies

Positioning

Maintain semi-recumbent position at 30-45 degrees at all times during BiPAP therapy, especially during and after any oral intake 5. This is a Level I recommendation that reduces aspiration risk even in mechanically ventilated patients.

Mode Selection Considerations

When clinically appropriate and if the patient can maintain adequate oxygenation:

• Prefer CPAP over BiPAP when possible for patients with dysphagia, as CPAP does not increase post-swallow inspiration rates 1
• If BiPAP is medically necessary, use the lowest effective pressure settings
• Consider mouthpiece ventilation as an alternative in appropriate neuromuscular disease patients 6

Feeding Route Decisions

For patients requiring BiPAP with confirmed aspiration risk 5, 4:

1. Initial approach: Nasogastric tube feeding (preferred over PEG in first 2-3 weeks)
2. If prolonged need anticipated (>2-3 weeks): Consider PEG tube, though recognize this does NOT eliminate aspiration risk
3. Enteral nutrition is mandatory over parenteral to prevent intestinal mucosal atrophy and bacterial translocation 5

Monitoring Protocol

Patients on BiPAP require 5, 7:

• Continuous observation in settings where staff are competent in NIV management
• Frequent clinical examination and physiological monitoring
• Serial chest radiographs if pneumonia suspected
• Temperature monitoring (fever prompts immediate pneumonia workup) 8

Special Consideration: Hemoptysis

In patients with hemoptysis using chronic BiPAP 9:

• Scant hemoptysis: Continue BiPAP (median expert rating: discontinue = 2/10)
• Mild-moderate hemoptysis: Continue BiPAP with caution (median expert rating: discontinue = 3/10)
• Massive hemoptysis: Strongly consider discontinuing BiPAP (median expert rating: discontinue = 8/10)

Critical Pitfall to Avoid

Silent aspiration occurs in 77% of aspiration events in ventilated patients 2. The absence of coughing or clinical distress does NOT indicate safety from aspiration. This is why instrumental evaluation (VSE or FEES) is essential rather than relying solely on bedside clinical signs in high-risk patients 3.

The subjective assessment of voluntary cough strength alone is unreliable for predicting aspiration risk and should not be used as the sole screening tool 3.

Implementation in Emergency/Acute Settings

For patients requiring urgent BiPAP initiation 10, 7:

• Place immediate NPO order
• Position at 30-45 degrees
• Perform rapid bedside water swallow screening when patient stabilizes
• Arrange speech-language pathology consultation within 24 hours for high-risk patients
• Consider prophylactic NG tube placement if BiPAP expected to continue >24 hours in patients with dysphagia risk factors